An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Active, not recruiting · NCT04076059 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) | Metastatic Hormone Sensitive Prostate Cancer | Active, not recruiting | Phase 3 | 2026-09-16 | NCT04076059 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astellas (Beijing) Pharmaceutical R&D Co., Ltd. | 1 |
28 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Site CN86001 | Guangzhou | China | 2 |
| Site CN86002 | Shanghai | China | 1 |
| Site CN86003 | Shanghai | China | 1 |
| Site CN86004 | Nanchang | China | 1 |
| Site CN86005 | Ürümqi | China | 1 |
| Site CN86009 | Changsha | China | 1 |
| Site CN86010 | Shanghai | China | 1 |
| Site CN86011 | Shenzhen | China | 1 |
| Site CN86012 | Tianjin | China | 1 |
| Site CN86013 | Shanghai | China | 2 |
| Site CN86014 | Shanghai | China | 2 |
| Site CN86016 | Changsha | China | 1 |
| Site CN86017 | Zhengzhou | China | 1 |
| Site CN86019 | Wuhan | China | 1 |
| Site CN86020 | Shenyang | China | 1 |
| Site CN86021 | Wuxi | China | 1 |
| Site CN86022 | Beijing | China | 1 |
| Site CN86023 | Changsha | China | 1 |
| Site CN86024 | Changchun | China | 1 |
| Site CN86025 | Fuzhou | China | 1 |
| Site CN86026 | Wuhan | China | 1 |
| Site CN86027 | Shanghai | China | 1 |
| Site CN86028 | Hangzhou | China | 1 |
| Site CN86029 | Zhengzhou | China | 1 |
| Site CN86032 | Suzhou | China | 1 |